Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001615774-17-005848)

Filing Details

Accession Number:: 0001615774-17-005848
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-10-23 19:25:18
Reporting Period:: 2017-10-19

Accepted Time:: 2017-10-23 19:25:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1621443	Zynerba Pharmaceuticals Inc.	ZYNE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1405685	Michael Rapp	9701 Collins Avenue, #1902-S Bal Harbor FL 33154		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-19	44,255	$9.59	1,398,370	No	4	P	Direct
Common Stock	Acquisiton	2017-10-20	30,000	$9.78	1,428,370	No	4	P	Direct
Common Stock	Acquisiton	2017-10-23	25,745	$9.94	1,454,115	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.